🟢 Amdocs is trading 5.85% up in pre-market with no new company-specific catalyst identified

Amdocs is trading at $65.00, up 5.85% in pre-market; no new Amdocs-specific catalyst explaining the October 21 pre-market move was identified.

• The company had no new earnings news; its latest earnings were reported August 5, and fiscal Q4 results are scheduled for November 3.
• Amdocs announced a 10-year VEON agreement on October 7, but that news does not establish a cause for this move.
• Major U.S. indices were modestly higher in the supplied market context; no trading-volume data was available.